MedTrace Logo

Comparison of ISOPURE and EYHANCE (Switzerland)

NCT05875922 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-03-18

No results posted yet for this study

Summary

This is a prospective randomised open-label study with the aim to compare the visual performance of the premium monofocal Isopure IOL versus the extended depth of focus Eyhance® IOL after phaco-emulsification cataract surgery.

Conditions

  • Cataract
  • Lens Opacities

Interventions

DEVICE

IOL implantation experimental (ISOPURE 1.2.3.)

Implantation of premium monofocal IOL ISOPURE 1.2.3.

DEVICE

IOL implantation active comparator (TECNIS Eyhance)

Implantation of EDOF IOL TECNIS Eyhance

Sponsors & Collaborators

  • targomedGmbH

    collaborator INDUSTRY

  • Beaver-Visitec International, Inc.

    lead INDUSTRY

Principal Investigators

  • Kristof Vandekerkchove, MD · Eye center Vista Alpina

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-31
Primary Completion
2025-03-12
Completion
2025-03-12

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05875922 on ClinicalTrials.gov